Abivax (ABVX) Convertible Debt (2023 - 2025)
Historic Convertible Debt for Abivax (ABVX) over the last 3 years, with Q3 2025 value amounting to $143.4 million.
- Abivax's Convertible Debt changed N/A to $143.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.4 million, marking a year-over-year change of. This contributed to the annual value of $121.8 million for FY2024, which is 4617.56% up from last year.
- Abivax's Convertible Debt amounted to $143.4 million in Q3 2025.
- In the past 5 years, Abivax's Convertible Debt registered a high of $143.4 million during Q3 2025, and its lowest value of $82.9 million during Q4 2023.
- Its 3-year average for Convertible Debt is $118.6 million, with a median of $119.7 million in 2024.
- In the last 5 years, Abivax's Convertible Debt surged by 4696.06% in 2024 and then tumbled by 869.53% in 2025.
- Quarter analysis of 3 years shows Abivax's Convertible Debt stood at $82.9 million in 2023, then skyrocketed by 46.96% to $121.8 million in 2024, then increased by 17.73% to $143.4 million in 2025.
- Its Convertible Debt was $143.4 million in Q3 2025, compared to $117.6 million in Q2 2025 and $117.2 million in Q1 2025.